These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 10498241)

  • 1. CpG: the double-edged sword.
    Paillard F
    Hum Gene Ther; 1999 Sep; 10(13):2089-90. PubMed ID: 10498241
    [No Abstract]   [Full Text] [Related]  

  • 2. Contribution of CpG motifs to the immunogenicity of DNA vaccines.
    Klinman DM; Yamshchikov G; Ishigatsubo Y
    J Immunol; 1997 Apr; 158(8):3635-9. PubMed ID: 9103425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylated CpG-containing plasmid activates the immune system.
    Cornélie S; Poulain-Godefroy O; Lund C; Vendeville C; Ban E; Capron M; Riveau G
    Scand J Immunol; 2004 Feb; 59(2):143-51. PubMed ID: 14871290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Causing a commotion in the blood: immunotherapy progresses from bacteria to bacterial DNA.
    Krieg AM; Wagner H
    Immunol Today; 2000 Oct; 21(10):521-6. PubMed ID: 11071532
    [No Abstract]   [Full Text] [Related]  

  • 5. Immune effects and mechanisms of action of CpG motifs.
    Krieg AM
    Vaccine; 2000 Nov; 19(6):618-22. PubMed ID: 11090712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of immunostimulatory CpG-DNA and its application to tuberculosis vaccine development.
    Yamamoto S; Yamamoto T; Nojima Y; Umemori K; Phalen S; McMurray DN; Kuramoto E; Iho S; Takauji R; Sato Y; Yamada T; Ohara N; Matsumoto S; Goto Y; Matsuo K; Tokunaga T
    Jpn J Infect Dis; 2002 Apr; 55(2):37-44. PubMed ID: 12082305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of CpG dinucleotides in DNA vaccines.
    Krieg AM; Yi AK; Schorr J; Davis HL
    Trends Microbiol; 1998 Jan; 6(1):23-7. PubMed ID: 9481820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of asthmatic response by immunostimulatory DNA sequences.
    Broide D; Cho JY; Miller M; Nayar J; Stachnick G; Castaneda D; Roman M; Raz E
    Springer Semin Immunopathol; 2000; 22(1-2):117-24. PubMed ID: 10944806
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunology of DNA vaccines: CpG motifs and antigen presentation.
    Manders P; Thomas R
    Inflamm Res; 2000 May; 49(5):199-205. PubMed ID: 10893042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CpG DNA augments the immunogenicity of plasmid DNA vaccines.
    Klinman DM; Ishii KJ; Verthelyi D
    Curr Top Microbiol Immunol; 2000; 247():131-42. PubMed ID: 10689784
    [No Abstract]   [Full Text] [Related]  

  • 11. [Immunostimulatory properties of CpG sequences in bacterial DNA].
    Smolarczyk R; Szala S
    Postepy Biochem; 2004; 50(4):296-303. PubMed ID: 15957525
    [No Abstract]   [Full Text] [Related]  

  • 12. Minding the Cs and Gs.
    Krieg AM
    Mol Ther; 2000 Mar; 1(3):209-10. PubMed ID: 10933935
    [No Abstract]   [Full Text] [Related]  

  • 13. Presence of CpG DNA and the local cytokine milieu determine the efficacy of suppressive DNA vaccination in experimental autoimmune encephalomyelitis.
    Lobell A; Weissert R; Eltayeb S; Svanholm C; Olsson T; Wigzell H
    J Immunol; 1999 Nov; 163(9):4754-62. PubMed ID: 10528174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bacterial DNA as immune cell activator.
    Lipford GB; Heeg K; Wagner H
    Trends Microbiol; 1998 Dec; 6(12):496-500. PubMed ID: 10036729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA methylation and TLR9 ligands: not only a matter of semantics.
    Baldari CT
    Immunol Lett; 2008 Nov; 121(1):84-5. PubMed ID: 18805440
    [No Abstract]   [Full Text] [Related]  

  • 16. Bacterial DNA containing CpG motifs stimulates lymphocyte-dependent protection of mice against lethal infection with intracellular bacteria.
    Elkins KL; Rhinehart-Jones TR; Stibitz S; Conover JS; Klinman DM
    J Immunol; 1999 Feb; 162(4):2291-8. PubMed ID: 9973506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro assay of immunostimulatory activities of plasmid vectors.
    Jiang W; Reich CF; Pisetsky DS
    Methods Mol Med; 2006; 127():55-70. PubMed ID: 16988446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Consequences of bacterial CpG DNA-driven activation of antigen-presenting cells.
    Sparwasser T; Lipford GB
    Curr Top Microbiol Immunol; 2000; 247():59-75. PubMed ID: 10689779
    [No Abstract]   [Full Text] [Related]  

  • 19. CpG DNA in cancer immunotherapy.
    Weiner GJ
    Curr Top Microbiol Immunol; 2000; 247():157-70. PubMed ID: 10689786
    [No Abstract]   [Full Text] [Related]  

  • 20. Identification of methylated CpG motifs as inhibitors of the immune stimulatory CpG motifs.
    Chen Y; Lenert P; Weeratna R; McCluskie M; Wu T; Davis HL; Krieg AM
    Gene Ther; 2001 Jul; 8(13):1024-32. PubMed ID: 11438837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.